FDA Adverse Event Malfunction Summary report: N

BD PHOENIX¿ NID

MDR report key: 18455466 · Received January 5, 2024

Report

Report Number
1119779-2024-00006
Event Type
Malfunction
Date Received
January 5, 2024
Date of Event
October 28, 2023
Report Date
April 11, 2024
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
LQM
UDI-DI
30382904480074
PMA / PMN Number
SEE H10
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FOLLOWING INFORMATION HAS BEEN UPDATED WITH CORRECTED AND/OR ADDITIONAL INFORMATION: D9: DEVICE AVAILABLE FOR EVAL? YES. D9: RETURNED TO MANUFACTURER ON: 10-NOV-2023. H6: INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR FALSE POSITIVE ESBL RESULTS WITH KLEBSIELLA OXYTOCA WHEN USING PHOENIX PANEL NMIC-311 (CATALOG NUMBER 449452) BATCH NUMBERS 3241410 AND 3202514. THE CUSTOMER DID NOT PROVIDE ISOLATE RETURNS BUT PROVIDED PANEL RETURNS AND PHOENIX GENERATED LAB REPORTS FOR THE INVESTIGATION. THE LAB REPORTS SHOW POSITIVE ESBL RESULTS FOR K. OXYTOCA FROM A URINE AND SPUTUM SAMPLE WHEN USING THE COMPLAINT BATCH. IT IS TO BE NOTED THAT BATCH 3202514 IS AN ID ONLY PANEL AND THEREFORE DOES NOT TEST FOR ESBL RESULTS AND WAS NOT USED IN INVESTIGATION TESTING. TO INVESTIGATE, THREE CUSTOMER RETURNED PANELS EACH FROM COMPLAINT BATCH 3241410 WERE INOCULATED WITH IN HOUSE ISOLATES K. OXYTOCA 18410 AND K. OXYTOCA 18411 AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL RESULTS. ADDITIONALLY, ONE CONTROL PANEL EACH FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE INOCULATED WITH IN HOUSE ISOLATES K. OXYTOCA 18410 AND K. OXYTOCA 18411 AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL RESULTS. DURING THE INVESTIGATION TESTING, THE EIGHT PANELS TESTED DID NOT RETURN ESBL POSITIVE RESULTS, THEREFORE, THIS COMPLAINT IS NOT CONFIRMED. THE BATCH HISTORY RECORDS WERE SATISFACTORY, AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED, AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. A REVIEW OF COMPLAINTS REVEALED NO OTHER COMPLAINTS ON THIS BATCH. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY.

Additional Manufacturer Narrative · 0

G.5. PMA/510(K)#: THE PANEL PHOENIX NMIC/ID-311 IS AN ANTIMICROBIAL RESISTANCE PANEL THAT CONSISTS OF A COMBINATION OF THE FOLLOWING 510K NUMBERS: K032299, K061355, K061327, K031912, K023444, K063824, K033560, K063573, K041384, K060217, K052269, K190905, K032655, K062944, K060444, K173252, K033362, K062207, K063811, K163637, K151320, K063301, K031530, K060447, K032567, K060257, K023634, K123404, K020322, K132674, K173523, K063486, K022129, K023858, K071623, K031699, K060447, K024153, K060214, K132909, K042932 H.3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. H3 OTHER TEXT :

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED WITH CORRECTED AND/OR ADDITIONAL INFORMATION: B3: DATE OF EVENT: 28-OCT-2023. B5: DESCRIBE EVENT: IT WAS REPORTED WHEN USING THE BD PHOENIX¿ NID A PATIENT URINE ISOLATE (B)(6) WAS RESULTED AS POSITIVE FOR EXTENDED SPECTRUM BETA-LACTAMASE (ESBL). THE RESULT WAS CONFIRMED TO BE NEGATIVE BY KIRBY BAUER CULTURE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 4.. B6: RELEVANT TESTS/LABORATORY DATA: BACTERIAL CULTURE - KIRBY BAUER. D1: MEDICAL DEVICE BRAND NAME: BD PHOENIX¿ NID. D2A: COMMON DEVICE NAME: GRAM NEGATIVE IDENTIFICATION PANEL. D2B: MEDICAL DEVICE TYPE: LQM. D4: MEDICAL DEVICE CATALOG #: 448007. D4: MEDICAL DEVICE LOT #: 3202514. D.4: MEDICAL DEVICE EXPIRATION DATE: 11-JUL-2024. D.5: UNIQUE IDENTIFIER (UDI) # (B)(4). H.4. DEVICE MANUFACTURE DATE: 21-JUL-2023.

Description of Event or Problem · 0

IT WAS REPORTED WHEN USING THE BD PHOENIX¿ NID A PATIENT URINE ISOLATE (420074512450) WAS RESULTED AS POSITIVE FOR EXTENDED SPECTRUM BETA-LACTAMASE (ESBL). THE RESULT WAS CONFIRMED TO BE NEGATIVE BY KIRBY BAUER CULTURE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 4.

Description of Event or Problem · 0

REPORT 2 OF 4 IT WAS REPORTED THAT DURING USE OF THE BD PANEL PHOENIX NMIC-311, THERE WAS FALSE POSITIVE ESBL ON K. OXYTOCA. THERE WAS NO ADVERSE IMPACT TO PATIENT REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHEN USING THE BD PHOENIX¿ NID A PATIENT URINE ISOLATE (B)(6) WAS RESULTED AS POSITIVE FOR EXTENDED SPECTRUM BETA-LACTAMASE (ESBL). THE RESULT WAS CONFIRMED TO BE NEGATIVE BY KIRBY BAUER CULTURE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 4.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
374204 BD PHOENIX¿ NID GRAM NEGATIVE IDENTIFICATION PANEL LQM BECTON, DICKINSON & CO. (SPARKS) 3202514 30382904480074
708989 BD PHOENIX¿ NID GRAM NEGATIVE IDENTIFICATION PANEL LQM BECTON, DICKINSON & CO. (SPARKS) 3202514 30382904480074

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown